Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.

Abstract

BACKGROUND Glioblastoma is associated with a poor prognosis in the elderly. Survival has been shown to increase among patients 70 years of age or younger when temozolomide chemotherapy is added to standard radiotherapy (60 Gy over a period of 6 weeks). In elderly patients, more convenient shorter courses of radiotherapy are commonly used, but the benefit of… (More)
DOI: 10.1056/NEJMoa1611977

Topics

5 Figures and Tables